BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7245137)

  • 1. Fibrin polymerization rate at different temperatures and in the presence of fragment D.
    Belitser VA; Varetskaja TV; Musjalkovskaja AA
    Thromb Res; 1981 Feb; 21(3):237-45. PubMed ID: 7245137
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the inhibition of fibrin assembly by fibrinogen fragment D.
    Williams JE; Hantgan RR; Hermans J; McDonagh J
    Biochem J; 1981 Sep; 197(3):661-8. PubMed ID: 7325975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of the inhibitory effect of fibrinogen and its degradation products on fibrin polymerization.
    Belitser VA; Lugovskoy EV; Musjalkovskaja AA; Gogolinskaja GK
    Thromb Res; 1982 Aug; 27(3):261-9. PubMed ID: 6291191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolation of the fragment D dimer from stabilized fibrin and a study of its antipolymerization action].
    Musialkovskaia AA; Khodorova EL; Pozdniakova TM
    Ukr Biokhim Zh; 1976; 48(2):139-43. PubMed ID: 941302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fibrin polymerization inhibitors on quantitative measurements of plasma fibrinogen.
    Hoffman M; Greenberg CS
    Am J Clin Pathol; 1987 Oct; 88(4):490-3. PubMed ID: 3661500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of soluble polymerized fibrin formed in the presence of excess fibrinogen fragment D.
    Knoll D; Hantgan R; Williams J; McDonagh J; Hermans J
    Biochemistry; 1984 Jul; 23(16):3708-15. PubMed ID: 6236846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticlotting properties of fragments D from human fibrinogen and fibrin.
    Haverkate F; Timan G; Nieuwenhuizen W
    Eur J Clin Invest; 1979 Aug; 9(4):253-5. PubMed ID: 118016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymorphism of fibrin equilibrium oligomers in the presence of fragment D].
    Gershkovich KB; Rozenfel'd MA
    Mol Biol (Mosk); 1989; 23(2):596-604. PubMed ID: 2770733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of fibrin monomer polymerization by fibrinolysis products--fragments D and DD].
    Belitser VA; Platonova TN; Musialkovskaia AA
    Dokl Akad Nauk SSSR; 1986; 291(4):1001-4. PubMed ID: 3803182
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
    Furlan M; Rupp C; Beck EA
    Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of end products of plasmin-mediated hydrolysis of fibrinogen and fibrin (EF and Ef fragments) on fibrinogen cross-linking].
    Leonova VB; Rozenfel'd MA; Biriukova MI; Kostanova EA; Vasil'eva MV
    Izv Akad Nauk Ser Biol; 2002; (5):522-7. PubMed ID: 12400374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin.
    Krajewski T; Nowak P; Cierniewski C
    Acta Biochim Pol; 1985; 32(2):144-54. PubMed ID: 4036448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition or acceleration of fibrin polymerization by monoclonal immunoglobulins and immunoglobulin fragments.
    Wisløff F; Michaelsen TE; Godal HC
    Thromb Res; 1984 Jul; 35(1):81-90. PubMed ID: 6474410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrin fragment beta 15-118. Inhibitory and complex-forming properties].
    Lugovskoĭ EV; Chudnovets VS; Makogonenko EM; Derzskaia SG; Gogolinskaia GK; Mikhalovskaia LI; Komissarenko SV
    Ukr Biokhim Zh (1978); 1995; 67(4):57-64. PubMed ID: 8553474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular organization of copolymers of fibrinogen-fibrin fragment].
    Rozenfel'd MA; Gershkovich KB
    Mol Biol (Mosk); 1988; 22(4):923-33. PubMed ID: 3185535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of D and DD fragments on fibrin polymerization.
    Loukinova NI; Platonova TN
    Ukr Biokhim Zh (1978); 1996; 68(4):17. PubMed ID: 9226804
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of inhibition of fibrinolysis and fibrinogenolysis by the end fibrinogen degradation products.
    Khavkina LS; Rozenfeld MA; Leonova VB
    Thromb Res; 1995 Apr; 78(2):173-87. PubMed ID: 7482434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of cross-linking of fibrinogen and its early structural homolog fragment X].
    Rozenfel'd MA; Kostanova EA; Vasil'eva MV; Leonova VB
    Izv Akad Nauk Ser Biol; 2001; (3):293-8. PubMed ID: 11433939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment E derived from both fibrin and fibrinogen stimulates interleukin-6 production in rat peritoneal macrophages.
    Lee ME; Rhee KJ; Nham SU
    Mol Cells; 1999 Feb; 9(1):7-13. PubMed ID: 10102564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin-fragment D complex formation.
    Belitser VA; Pozdnjakova TM; Platonova TN; Vovk EV
    Thromb Res; 1981 Mar; 21(6):565-72. PubMed ID: 7268700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.